Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation.

Calcitonin inhibits both osteoclast formation and bone resorption, and is a primary treatment for patients with hypercalcemia and increased bone turnover. However, the clinical utility of calcitonin is limited because patients become refractory to calcitonin after several days (the calcitonin "escap...

Descrizione completa

Dettagli Bibliografici

Pubblicato in:	J Clin Invest
Autori principali:	Takahashi, S, Goldring, S, Katz, M, Hilsenbeck, S, Williams, R, Roodman, G D
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	American Society for Clinical Investigation 1995
Soggetti:	Research Article
Accesso online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC295397/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7814611/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117634
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!